|Articles|November 1, 2005

Pharmacy Times

  • Volume 0
  • 0

Consider Exhaled Nitric Oxide Levels

Nitric oxide levels in apatient's breath may be a betterindicator for determiningcorticosteroid dose for childrenwith moderate-to-severe asthma,according to the results ofa study reported in the AmericanJournal of Respiratory andCritical Medicine (October2005). Researchers basedinhaled corticosteroid treatmentfor 39 children with asthma,average age 12 years,mainly on exhaled nitric oxidelevels, while also consideringsymptoms. Inhaled corticosteroidtreatment levels administeredto 46 children ofapproximately the same agewere based totally on symptoms.All of the patients hadatopic asthma.

The 1-year study involvedmeasuring exhaled nitric oxidein the test group 5 times. Airwayhyperresponsiveness andlung function were determinedin both groups at the beginningand end of the study. The findingsindicated that participantsin the nitric oxide group had 8severe exacerbations duringthe study, compared with 18exacerbations in patients treatedbased on symptoms.

Articles in this issue

about 20 years ago

COMPOUNDING HOTLINE

about 20 years ago

Compounding: Treating Mouth Ulcers

about 20 years ago

CAN YOU READTHESE Rxs?

about 20 years ago

RxWise

about 20 years ago

AutoBox

about 20 years ago

LucidLinkWireless Security

about 20 years ago

MILT 2.0

about 20 years ago

PACMED

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME